Option chain shows key data for Artiva Biotherapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Artiva Biotherapeutics.

Artiva Biotherapeutics (NASDAQ:ARTV) Stock, Option Chain

Artiva Biotherapeutics

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.

Chicago,,Il,-,July,27,,2017:,American,Airlines,Plane,On

News

Upgrades

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

ARQT

ARTV

CTXR

NUVL

This American Airlines Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday

Stock market analysts

Initiation

MTVA

This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Genetic,Research,And,Biotech,Science,Concept.,Human,Biology,And,Pharmaceutical

Analyst Color

Biotech

Equities

Health Care

Price Target

IPOs

General

Artiva Biotherapeutics raised $167 million in its July IPO to advance its innovative cell therapies for autoimmune diseases and cancers. Lead candidate AlloNK, in clinical trials for lupus, is projected to drive significant revenue by 2038.

Artiva Biotherapeutics&#39; Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics Inc

JP Morgan analyst Doug Anmuth maintains Snap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) with a Underweight and lowers the price target from $11 to $10.

SNAP

JP Morgan Maintains Underweight on Snap, Lowers Price Target to $10

Benchmark analyst Josh Sullivan maintains Planet Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) with a Buy and raises the price target from $4 to $7.

Benchmark Maintains Buy on Planet Labs, Raises Price Target to $7

Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) will release its fourth-quarter financial results, after the closing <a href="https://www.benzinga.com/quote/F/earnings">bell, on Wednesday, Feb. 5, 2025.</a>
Analysts expect the Dearborn, Michigan-based company to report quarterly earnings at 33 cents per share, up from 29 cents per share in the year-ago period. Ford projects quarterly revenue of $43.25 billion, compared to $43.21 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
The company has beaten analyst estimates for revenue in two straight quarters and eight of the past 10 quarters. The company has also topped analyst expectations for earnings per share in one straight quarter and five of the past 10 quarters overall.
Ford shares gained 2.7% to close at $10.16 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/F/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Jefferies analyst Philippe Houchois downgraded the stock from Hold to Underperform and cut the price target from $12 to $9 on Dec. 16, 2024. This analyst has an accuracy rate of 74%.</li>
<li>Wolfe Research analyst Emmanuel Rosner downgraded the stock from Peer Perform to Underperform on Dec. 5, 2024. This analyst has an accuracy rate of 74%.</li>
<li>RBC Capital analyst Tom Narayan reiterated a Sector Perform rating with a price target of $10 on Oct. 29, 2024. This analyst has an accuracy rate of 69%.</li>
<li>Goldman Sachs analyst Mark Delaney upgraded the stock from Neutral to Buy and raised the price target from $12 to $13 on Oct. 1, 2024. This analyst has an accuracy rate of 76%.</li>
<li>Morgan Stanley analyst Adam Jonas downgraded the stock from Overweight to Equal-Weight and slashed the price target from $16 to $12 on Sept. 25, 2024. This analyst has an accuracy rate of 63%.</li>
</ul>
Considering buying Ford stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="582" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05021340/image-32-1024x582.png" alt="" class="wp-image-766324" style="width:536px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05021340/image-32-1024x582.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05021340/image-32-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05021340/image-32-768x437.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05021340/image-32.png 1127w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43460681/jim-cramer-says-no-to-bigbear-ai-recommends-buying-this-tech-stock">Jim Cramer Says No To BigBear.ai, Recommends Buying This Tech Stock</a></li>
</ul>

Earnings

Ford Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

JP Morgan analyst Doug Anmuth maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Overweight and lowers the price target from $232 to $220.

GOOGL

JP Morgan Maintains Overweight on Alphabet, Lowers Price Target to $220

<ul>
<li>Keysight solution validates performance of first mission-critical-push-to-talk test case based on 3GPP Evolved Universal Terrestrial Radio Access model</li>
</ul>

KEYS

Keysight And Alea Validated First 3GPP EUTRA Mission Critical Test Case

New York Times Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYT#NYSE">NYT</a>) shares are trading lower in the premarket <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">session on Wednesday</a>.
Here&#8217;s what the company <a href="https://nytco-assets.nytimes.com/2025/02/Q4-2024-Earnings-Release-Final-for-Distribution.pdf" target="_blank" rel="noreferrer noopener">reported</a>:
<ul>
<li>Fourth-quarter adjusted earnings per share of 80 cents beat the street view of 74 cents. </li>
<li>Quarterly sales of $726.6 million missed the analyst consensus estimate of $726.65 million.</li>
<li>350,000 net digital-only subscribers gained; the total hovers at 11.43 million.</li>
<li>Digital-only ARPU rose 4.4% to $9.65 due to price increases and subscriber transitions.</li>
<li>Digital subscription revenues grew 16.0%, while digital advertising revenues increased 9.5%.</li>
<li>Total subscription revenues increased 8.4% to $466.6 million in the fourth quarter. </li>
<li>Advertising revenues increased 0.6% to $165.1 million</li>
<li>Digital advertising revenues increased 9.5%</li>
<li>Print advertising revenues decreased 16.4%.</li>
<li>Adjusted operating profit margin was 23.5%, a year-over-year increase of approximately 70 basis points.</li>
</ul>
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/general/health-care/25/01/43321236/rfk-jr-and-big-pharma-stocks-to-watch-as-health-secretary-hopeful-answers-pointed-questions-on-drugs-insurance-trump-exec-orders" rel="noreferrer noopener">RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders</a>
The New York Times approved a $350 million share repurchase program and declared a 5 cent increase in its dividend to 18 cents per share. The dividend is payable on April 17.
New York Times CEO Meredith Kopit Levien said, &#8220;Deep engagement fueled our multi-revenue stream model, and enhanced our durability even in a dynamic information ecosystem.&#8221;
In its<a href="https://event.choruscall.com/mediaframe/webcast.html?webcastid=LE3YM0cp" target="_blank" rel="noreferrer noopener"> conference call</a>, Levien announced the company will have a pipeline of new content, shows, features, games, and enhancements this year. There is also strong demand for the company&#8217;s lifestyle products, she added. 
When it comes to sports, The Athletic&#8217;s revenues grew 29% in the fourth quarter of 2024 to $49.7 million from $38.5 million in the fourth quarter of 2023.
Price Action: New York Times shares are trading lower by 11.3% to $49.55 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43475015/spotifys-strong-subscriber-growth-and-rising-margins-keep-analysts-bullish" target="_blank" rel="noreferrer noopener">Spotify Is Still One Of Top 4 Best Ideas For 2025: Analyst</a></li>
</ul>
Image: Shutterstock

Guidance

Movers

New York Times Beats Q4 Earnings But Misses Sales, CEO Hints At Pipeline Of New Content And Shows

Vistra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) has outperformed the market over the past 5 years by 37.11% on an annualized basis producing an average annual return of 49.49%. Currently, Vistra has a market capitalization of $58.36 billion. 
Buying $1000 In VST: If an investor had bought $1000 of VST stock 5 years ago, it would be worth $7,702.74 today based on a price of $171.54 for VST at the time of writing.
<h3>Vistra's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738771208_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Vistra 5 Years Ago Would Be Worth Today

CJMB

Trading Halt: Halt status updated at 11:00:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Guggenheim analyst Michael Morris maintains Fox (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>) with a Buy and raises the price target from $55 to $60.

FOXA

Guggenheim Maintains Buy on Fox, Raises Price Target to $60

JP Morgan analyst Harlan Sur maintains NXP Semiconductors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) with a Neutral and lowers the price target from $260 to $240.

NXPI

JP Morgan Maintains Neutral on NXP Semiconductors, Lowers Price Target to $240

Keefe, Bruyette &amp; Woods analyst Aidan Hall maintains PJT Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJT#NYSE">PJT</a>) with a Market Perform and raises the price target from $152 to $177.

Keefe, Bruyette & Woods Maintains Market Perform on PJT Partners, Raises Price Target to $177

The U.S. services sector continued to grow in January 2025, though at a slower pace than expected, highlighting uncertainty as businesses brace <a href="https://www.benzinga.com/news/econ-s">for potential tariff impacts.</a>
The latest survey from the Institute for Supply Management revealed that the Services PMI fell to 52.8% in January, down from 54% in December, and below the 54.3% forecast by economists, as per TradingEconomics. While expansion persists, the slowdown suggests businesses are feeling pressure from rising costs and trade policy uncertainties.
Despite the overall softness, January marked the second consecutive month in which all four key subindexes—Business Activity, New Orders, Employment, and Supplier Deliveries—remained in expansion territory. 
Yet, concerns over tariffs weighed on sentiment.
"Many panelists also mentioned preparations or concerns related to potential U.S. government tariff actions," said Steve Miller, chair of ISM's survey committee. 
Industry respondents echoed these worries, with contacts in professional, scientific and technical Services indicating that the threat of tariffs is leading to higher price pressures. Respondents in real estate, rental, and leasing flagged concerns about the cost of materials and project work going forward.
Weather-related disruptions also emerged as a possible factor affecting business activity and production levels, according to the survey.
<h3 class="wp-block-heading">Key ISM Services PMI Data – January 2025</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Index Series</th>
<th>Jan 2025</th>
<th>Dec 2024</th>
<th>Change</th>
<th>Direction</th>
<th>Rate of Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>Services PMI</td>
<td>52.8</td>
<td>54.0</td>
<td>-1.2</td>
<td>Growing</td>
<td>Slower</td>
</tr>
<tr>
<td>Business Activity/Production</td>
<td>54.5</td>
<td>58.0</td>
<td>-3.5</td>
<td>Growing</td>
<td>Slower</td>
</tr>
<tr>
<td>New Orders</td>
<td>51.3</td>
<td>54.4</td>
<td>-3.1</td>
<td>Growing</td>
<td>Slower</td>
</tr>
<tr>
<td>Employment</td>
<td>52.3</td>
<td>51.3</td>
<td>+1.0</td>
<td>Growing</td>
<td>Faster</td>
</tr>
<tr>
<td>Supplier Deliveries</td>
<td>53.0</td>
<td>52.5</td>
<td>+0.5</td>
<td>Slowing</td>
<td>Faster</td>
</tr>
<tr>
<td>Inventories</td>
<td>47.5</td>
<td>49.4</td>
<td>-1.9</td>
<td>Contracting</td>
<td>Faster</td>
</tr>
<tr>
<td>Prices</td>
<td>60.4</td>
<td>64.4</td>
<td>-4.0</td>
<td>Increasing</td>
<td>Slower</td>
</tr>
<tr>
<td>Backlog of Orders</td>
<td>44.8</td>
<td>44.3</td>
<td>+0.5</td>
<td>Contracting</td>
<td>Slower</td>
</tr>
<tr>
<td>New Export Orders</td>
<td>52.0</td>
<td>50.1</td>
<td>+1.9</td>
<td>Growing</td>
<td>Faster</td>
</tr>
</tbody>
</table>
</figure>
<h3 class="wp-block-heading">Labor Market Remains Strong In Services Sector</h3>
The job market in service-related industries remained resilient, with private employers adding 190,000 jobs in January, according to <a href="https://www.benzinga.com/25/02/43494246/private-employment-rises-by-183000-beats-estimates-in-january-consumer-facing-industries-drove-hiring">the ADP National Employment Report.</a> 
In contrast, goods-producing industries shed 6,000 jobs, signaling a stark divide between the two sectors.
Within services, trade, transportation, and utilities led hiring with 56,000 new jobs, while leisure and hospitality closely followed, adding 54,000 positions. 
This data underscores the continued strength of consumer-driven industries, even amid broader economic uncertainty.
&#8220;Consumer-facing industries drove hiring, while job growth was weaker in business services and production,&#8221; said ADP chief economist Nela Richardson. 
<h3 class="wp-block-heading">Market Reactions: Stocks Fall, Gold Shatters Records</h3>
Stocks negatively reacted following the publications of the ISM Services PMI report, with the S&amp;P 500 index – tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) – further sliding into negative territory, down 0.5% by 10:20 a.m. ET. 
Tech stocks – tracked by the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) – were 0.6% lower, as Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) fell 8.4%, and Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) was down 10%, weighing on tech-heavy indices.
Outside of Wall Street, gold continued to shine, further extending its all-time highs to $2,875 per ounce. The SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>) has now rallied 8.7% year-to-date, with the bullion marking the strongest start to the year since 1980. 
Treasury yields fell, particularly on longer-dated maturities, with yields on the 30-year Treasury down 8 basis points to 4.72%. The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) rallied 1.4%, eyeing its third straight session of gains. 
Other than weaker investor sentiment on risky assets, Treasuries benefited from safe-haven demand after President Donald Trump escalated tariff disputes with China and proposed a U.S.-led redevelopment plan for Gaza.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) was flat at $98,400. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/earnings-beats/25/02/43496870/janus-henderson-is-a-turnaround-story-with-growing-suite-of-fixed-income-etfs-analyst">Janus Henderson Is A &#8216;Turnaround Story&#8217; With Growing Suite Of Fixed Income ETFs: Analyst</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Large Cap

Macro Economic Events

Broad U.S. Equity ETFs

Commodities

Econ #s

Economics

Tech

ETFs

$BTC

GOOG

iShares Trust Barclays 20+ Year Treasury Bond Fund

US Services Growth Slows In January As Tariff Concerns Mount

JMP Securities analyst Andrew Boone reiterates Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) from Market Perform to Market Perform.

Reiteration

JMP Securities Reiterates Market Perform on Alphabetto Market Perform

WIIM

BNTX

MRNA

Shares of vaccine stocks are trading higher as the sector sees volatility amid Robert F. Kennedy Jr.'s nomination as HHS secretary. Sen. Senator Bill Cassidy said Kennedy committed to cooperation and would not remove vaccine information from the CDC website if confirmed.

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains Hamilton Lane (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLNE#NASDAQ">HLNE</a>) with a Market Perform and raises the price target from $158 to $168.

HLNE

Keefe, Bruyette & Woods Maintains Market Perform on Hamilton Lane, Raises Price Target to $168

HC Wainwright &amp; Co. analyst Edward White reiterates Valneva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VALN#NASDAQ">VALN</a>) with a Buy and maintains $18 price target.

VALN

HC Wainwright & Co. Reiterates Buy on Valneva, Maintains $18 Price Target

A strategic Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) reserve remains a topic of discussion after &#8216;Crypto Czar&#8217; David Sacks on Tuesday announced it would be one of the <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43477333/crypto-czar-sacks-says-potential-bitcoin-reserve-to-be-one-of-crypto-committees-first-priorities">digital assets committee&#8217;s first priorities.</a>
What Happened: Despite the announcement the odds of a reserve being implemented in 2025 have dropped from a peak of 68.5% in January to 58% on prediction market site Kalshi. 
At the press conference, Sacks further stated that a possible inclusion of Bitcoin in the newly-incepted <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43473182/could-the-trump-established-sovereign-wealth-fund-invest-in-bitcoin-nvidia-tiktok">sovereign wealth fund</a> would fall under the responsibility of the soon-to-be Secretary of Commerce Howard Lutnick.
Amid this ongoing debate, MicroStrategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) executive chairman Michael Saylor stirred excitement, tweeting about a &#8220;Big Strategy Day&#8221; on Wednesday. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">₿ig Strategy Day
&mdash; Michael Saylor&#x26a1;&#xFE0F; (@saylor) <a href="https://twitter.com/saylor/status/1887124093297729872?ref_src=twsrc%5Etfw">February 5, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Coinvo, a Bitcoin investor and trader, emphasized that strategic Bitcoin reserves are being established globally, suggesting the U.S. could just be at the beginning of a larger trend.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Strategic <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> reserves are being built all over the world. This is just the beginning, and you're a part of it! &#x1f680; <a href="https://t.co/l4avAOarzZ">pic.twitter.com/l4avAOarzZ</a>
&mdash; Coinvo (@ByCoinvo) <a href="https://twitter.com/ByCoinvo/status/1887127788462743792?ref_src=twsrc%5Etfw">February 5, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43473182/could-the-trump-established-sovereign-wealth-fund-invest-in-bitcoin-nvidia-tiktok">Could The Trump-Established Sovereign Wealth Fund Invest In Bitcoin, Nvidia, TikTok?</a>
Why It Matters: Crypto trader OSF noted that many expected a U.S. Bitcoin reserve to be announced immediately after Trump's inauguration, leading to instant Bitcoin purchases. 
When this didn't occur, speculation turned to David Sacks, who has stressed the need for thorough research.
OSF <a href="https://x.com/osf_rekt/status/1886874591370400145">argues</a> that this short-term speculation has created market volatility, benefiting savvy, patient investors who can capitalize on others' impatience. 
He notes that government actions take time, and traders should brace for a prolonged period of volatility.
The Bitcoin Therapist <a href="https://x.com/TheBTCTherapist/status/1886971995327213591">highlighted</a> the irony that while 99% of people and institutions lack Bitcoin exposure, the U.S. government is considering a strategic Bitcoin reserve. 
He sees this as the start of a massive financial transformation, underscoring the misunderstanding and undervaluation of Bitcoin.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43270841/how-donald-trump-could-make-the-strategic-bitcoin-reserve-a-reality">How Donald Trump Could Make The Strategic Bitcoin Reserve A Reality</a></li>
</ul>
Image: Shutterstock

MSTR

Michael Saylor Hints At '₿ig Strategy Day' As Chances Of Bitcoin Reserve Odds On Kalshi Fall

Craig-Hallum analyst Eric Stine maintains Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) with a Buy and lowers the price target from $123 to $101.

Comments

Artiva Biotherapeutics

Artiva Biotherapeutics (ARTV) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga